ASND
Ascendis Pharma AS
227.90$
+0.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures per share in EUR.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.85 | 2.43 | 1.69 | 0.63 | 0.99 | 2.91 | 1.68 | 2.47 | 3.50 | 3.99 | 3.88 | 5.05 | 15.43 | |
| 0.13 | 0.34 | 0.13 | 0.20 | 0.19 | 0.23 | 0.29 | 0.49 | 0.37 | 0.44 | 0.34 | 0.47 | 1.51 | |
| 0.72 | 2.09 | 1.55 | 0.43 | 0.80 | 2.67 | 1.39 | 1.98 | 3.14 | 3.55 | 3.55 | 4.58 | 13.92 | |
| 1.98 | 1.61 | 1.24 | 1.46 | 1.26 | 1.33 | 1.44 | 1.13 | 1.10 | 1.22 | 0.89 | 1.09 | 4.01 | |
| 1.11 | 1.13 | 1.27 | 1.26 | 1.16 | 1.32 | 1.59 | 1.65 | 1.83 | 2.20 | 2.25 | 2.51 | 8.25 | |
| 3.11 | 2.74 | 2.42 | 2.75 | 2.45 | 2.67 | 3.13 | 2.81 | 2.96 | 3.39 | 3.16 | 3.65 | 12.32 | |
| -2.39 | -0.65 | -0.86 | -2.32 | -1.65 | 0.01 | -1.74 | -0.83 | 0.18 | 0.16 | 0.39 | 0.93 | 1.60 | |
| 0.44 | 1.21 | 1.36 | 0.34 | 0.43 | 0.95 | 0.75 | 0.52 | 0.32 | 1.00 | 1.06 | 0.21 | 2.40 | |
| -2.87 | -1.43 | -2.26 | -1.90 | -1.68 | -0.63 | -1.56 | -0.55 | -0.94 | -0.43 | -0.76 | 3.42 | 1.48 | |
| 0.01 | 0.10 | 0.04 | 0.00 | 0.02 | 0.02 | 0.02 | 0.06 | 0.06 | 0.11 | -10.67 | 0.34 | -9.58 | |
| -2.88 | -1.53 | -2.30 | -1.91 | -1.69 | -0.64 | -1.58 | -0.61 | -1.00 | -0.54 | 9.91 | 3.08 | 11.06 | |
| -2.35 | -1.20 | -0.82 | -1.53 | -1.21 | -0.63 | -0.74 | 0.04 | -0.87 | 0.65 | 0.37 | 1.00 | 1.14 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.